Ulrich Herbert Thome
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ulrich Herbert Thome has a total of 173 co-authors. Here are the top co-authors by number of shared publications:
- Mandy Laube
Department of Pediatrics, Division of Neonatology, University of Leipzig, 04103 Leipzig, Germany
9 shared publications - Matthias Knüpfer
Hospital for Children and Adolescents, University of Leipzig , 04103 Leipzig , Germany
3 shared publications Roland Hentschel
3 shared publicationsAndrea Calkovska
2 shared publications- Anton Hubertus van Kaam
Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, Amsterdam, Netherlands
2 shared publications - Benjamin Walter Ackermann
Division of Neonatology, Department of Women’s and Children’s Medicine, Medical Faculty, Leipzig University, 04103 Leipzig, Germany
2 shared publications
Latest Publications
- Open Access
Target Versus Modified-Standard Fortification of Human Milk and Growth of Very Low Birth Weight Infants: A Double-Blind Randomized Trial
Background/Objectives: Individualized (“target”) fortification of human milk is promoted to improve growth and subsequent neurodevelopment in very low birth weight (VLBW) infants, because standard fortifiers may not provide sufficient protein given the considerable intra- and interindividual variability of human-milk composition. We compared modified-standard fortification (MSF), an optimized high-protein standard regimen, with high-protein target fortification (TFO). Methods: In a single-center, double-blind randomized trial, VLBW infants (24 + 0 – 31 + 6 weeks) receiving 100 mL/kg/d of standard fortified human milk were randomized to MSF (protein and medium-chain triglycerides added to standard fortifier) or TFO until 36 weeks postmenstrual age (PMA). The primary outcome was weight-gain velocity from randomization to 36 weeks PMA; the trial was powered to detect a difference of 0.666 standard deviations. Results: Weight-gain velocity did not differ between the groups (MSF n = 54, TFO n = 52; MSF − TFO − 0.18 g/kg/d, 95% CI −1.02 to +0.67, p = 0.68), nor did anthropometry, z-scores, skinfold thickness or cranial widths at 36 weeks PMA, or Bayley-III scores at 24 months. Conclusions: Compared with optimized high-protein standard fortification, high-protein target fortification did not improve growth or neurodevelopmental outcomes.
Open AccessTarget Versus Modified-Standard Fortification of Human Milk and Growth of Very Low Birth Weight Infants: A Double-Blind Randomized Trial
Background/Objectives: Individualized (“target”) fortification of human milk is promoted to improve growth and subsequent neurodevelopment in very low birth weight (VLBW) infants, because standard fortifiers may not provide sufficient protein given the considerable intra- and interindividual variability of human-milk composition. We compared modified-standard fortification (MSF), an optimized high-protein standard regimen, with high-protein target fortification (TFO). Methods: In a single-center, double-blind randomized trial, VLBW infants (24 + 0 – 31 + 6 weeks) receiving 100 mL/kg/d of standard fortified human milk were randomized to MSF (protein and medium-chain triglycerides added to standard fortifier) or TFO until 36 weeks postmenstrual age (PMA). The primary outcome was weight-gain velocity from randomization to 36 weeks PMA; the trial was powered to detect a difference of 0.666 standard deviations. Results: Weight-gain velocity did not differ between the groups (MSF n = 54, TFO n = 52; MSF − TFO − 0.18 g/kg/d, 95% CI −1.02 to +0.67, p = 0.68), nor did anthropometry, z-scores, skinfold thickness or cranial widths at 36 weeks PMA, or Bayley-III scores at 24 months. Conclusions: Compared with optimized high-protein standard fortification, high-protein target fortification did not improve growth or neurodevelopmental outcomes.
- 29 September 2026
- Published by S. Karger AG in Neonatology
- p. 1
Obstacles to overcome when performing pan-European multicentre studies in extremely preterm infants: results of a survey among researchers of the Pulmonary Research Consortium of ESPR
Introduction: Clinical studies around the world showed large variations in the management and outcomes of extremely preterm infants (EPI) delivered <28 weeks´ gestation. Differences in ethical and legal requirements for conducting clinical research impede patient data collection from different countries. This pre-inquiry aimed to investigate the obstacles for successfully executing a multicentre study in EPI across European tertiary neonatal units. Methods: Between June and September 2025, we sent out a questionnaire on care structures and management of EPI and ethical requirements for conducting an observational study to the previously identified national representatives of all 24 European countries within the European Society for Paediatric Research Pulmonary Research Consortium. Results: Our survey found wide variations in care structures across European countries which were reflected by different inter-hospital transfer strategies before discharge, differences in data accessibility and follow-up data availability. We observed varying use of outcome definitions, discrepancies in their execution and availability of underlying physiological measures limiting the reliability on retrospective data. Differences in ethical requirements present further issues for successfully performing multicentre studies in Europe. Conclusion: These results highlight the obstacles researchers are faced with when planning multicentre studies involving EPI across Europe.
- 29 September 2026
- Published by S. Karger AG in Neonatology
- p. 1
Obstacles to overcome when performing pan-European multicentre studies in extremely preterm infants: results of a survey among researchers of the Pulmonary Research Consortium of ESPR
Introduction: Clinical studies around the world showed large variations in the management and outcomes of extremely preterm infants (EPI) delivered <28 weeks´ gestation. Differences in ethical and legal requirements for conducting clinical research impede patient data collection from different countries. This pre-inquiry aimed to investigate the obstacles for successfully executing a multicentre study in EPI across European tertiary neonatal units. Methods: Between June and September 2025, we sent out a questionnaire on care structures and management of EPI and ethical requirements for conducting an observational study to the previously identified national representatives of all 24 European countries within the European Society for Paediatric Research Pulmonary Research Consortium. Results: Our survey found wide variations in care structures across European countries which were reflected by different inter-hospital transfer strategies before discharge, differences in data accessibility and follow-up data availability. We observed varying use of outcome definitions, discrepancies in their execution and availability of underlying physiological measures limiting the reliability on retrospective data. Differences in ethical requirements present further issues for successfully performing multicentre studies in Europe. Conclusion: These results highlight the obstacles researchers are faced with when planning multicentre studies involving EPI across Europe.
- Open Access
- 7 September 2025
- Published by S. Karger AG in Neonatology
- Vol. 122 (6) , 677-684
Management of Apnoea in Extremely Preterm Infants: A European Survey
Introduction: Episodes of apnoea are common in extremely preterm infants (EPIs) and usually treated with caffeine and respiratory support. Understanding differences in apnoea definitions, monitoring practices, and use of respiratory stimulants is essential to improve future treatment. Methods: Between March and July 2024, one lead consultant at European tertiary neonatal intensive care units (NICUs) was invited to complete a web-based survey on respiratory practices in EPIs. We sought information how they defined apnoea and monitored for it, and how they treated it with caffeine, doxapram, and non-invasive respiratory support. Results: We received replies from 447/721 (62%) NICUs across 24 European countries. Most NICUs (74%) use both electrocardiogram electrodes and pulse oximetry for apnoea monitoring. All NICUs reported using caffeine citrate, with 102 centres (23%) starting it in the delivery room. The median loading, maintenance and maximum maintenance doses used are 20 mg/kg, 5 and 10 mg/kg/day, respectively. Caffeine is occasionally given twice daily in some NICUs (30%) and stopped at 34–35 weeks of postmenstrual age at most of them (74%). Doxapram is used at 111 (25%) NICUs, with geographical differences. Strategies for the use and escalation of non-invasive respiratory support in case of persistent apnoea are not clearly defined. Automatic closed-loop oxygen delivery is used at 25% of NICUs. Conclusion: Despite consistency in the dosing and weaning of caffeine, there is much variation in the management of apnoea in preterm infants across Europe. Future research should focus on timing and dosage of caffeine, the use of doxapram, and strategies for optimising non-invasive respiratory support.
- 7 September 2025
- Published by S. Karger AG in Neonatology
- Vol. 122 (6) , 677-684
Open AccessManagement of Apnoea in Extremely Preterm Infants: A European Survey
Introduction: Episodes of apnoea are common in extremely preterm infants (EPIs) and usually treated with caffeine and respiratory support. Understanding differences in apnoea definitions, monitoring practices, and use of respiratory stimulants is essential to improve future treatment. Methods: Between March and July 2024, one lead consultant at European tertiary neonatal intensive care units (NICUs) was invited to complete a web-based survey on respiratory practices in EPIs. We sought information how they defined apnoea and monitored for it, and how they treated it with caffeine, doxapram, and non-invasive respiratory support. Results: We received replies from 447/721 (62%) NICUs across 24 European countries. Most NICUs (74%) use both electrocardiogram electrodes and pulse oximetry for apnoea monitoring. All NICUs reported using caffeine citrate, with 102 centres (23%) starting it in the delivery room. The median loading, maintenance and maximum maintenance doses used are 20 mg/kg, 5 and 10 mg/kg/day, respectively. Caffeine is occasionally given twice daily in some NICUs (30%) and stopped at 34–35 weeks of postmenstrual age at most of them (74%). Doxapram is used at 111 (25%) NICUs, with geographical differences. Strategies for the use and escalation of non-invasive respiratory support in case of persistent apnoea are not clearly defined. Automatic closed-loop oxygen delivery is used at 25% of NICUs. Conclusion: Despite consistency in the dosing and weaning of caffeine, there is much variation in the management of apnoea in preterm infants across Europe. Future research should focus on timing and dosage of caffeine, the use of doxapram, and strategies for optimising non-invasive respiratory support.
- Open Access
- 20 August 2025
- Published by Elsevier in Materials & Design
- Vol. 258
Biomimetic elastin-collagen hybrid hydrogels crosslinked by energetic electrons: towards a tunable in vitro extracellular matrix model of the lung
- 20 August 2025
- Published by Elsevier in Materials & Design
- Vol. 258
Open AccessBiomimetic elastin-collagen hybrid hydrogels crosslinked by energetic electrons: towards a tunable in vitro extracellular matrix model of the lung
- Open Access
- 19 May 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1514853
CPAP caps are associated with restricted head growth and altered skull morphology in newborn infants
Background: Continuous positive airway pressure (CPAP) devices for preterm infants are commonly affixed using snug-fitting caps. Monitoring of head growth is standard practice in preterm infants, as stagnant head growth has been associated with impaired neurodevelopmental outcome. However, a stagnant head circumference may not mean stagnant head growth since vertical head distortion has been repeatedly observed. Previously established centiles for ear-to-ear distances and head volume indices allow the evaluation of three-dimensional head growth. We hypothesized that CPAP duration may be associated with restricted head circumference gain, altered skull morphology, and possibly neurodevelopment.Patients and methods: All 4590 infants treated with CPAP in the neonatal wards of Leipzig University Medical Center between 2009 and 2020 were included in our study. Body weight, body length, occipitofrontal head circumference (OFC), and transvertical (vEED) and transfontanellar ear-to-ear (fEED) distances were measured repeatedly. Head eccentricity (ECC) (a measure of disproportional head growth) and head volume indices (HVI) were calculated. Anthropometric data were z-transformed. A total of 367 infants were followed up for assessment of neurodevelopmental outcomes using the Bayley Scales of Infant and Toddler Development (third edition). Associations between cumulative cap time and anthropometric data were examined using unconditional growth models with linear mixed effects. Associations between head growth development and neurodevelopmental outcome were examined by correlating individual regression slopes of anthropometric data with Bayley scores.Results: Cumulative cap time was negatively associated with z-scores of OFC (, ), vEED (, ], fEED (, ), and HVI (, ), while it was positively associated with ECC (, ). Individual OFC z-score slopes show low correlation with cognition (R = 0.07), language (R = 0.06), and motor (R = 0.01) Bayley scores. Individual vEED z-scores slopes show low correlation with cognition (R = 0.10), language (R = 0.08), and motor (R = 0.07) Bayley scores.Conclusion: CPAP caps are associated with vertical and horizontal head growth restriction and altered infant head morphology, as indicated by increasing eccentricity. The correlation of the altered growth pattern with neurodevelopmental outcome was negligible. Our findings have clinical implications for the assessment of head growth development during CPAP therapy.- 19 May 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1514853
Open AccessCPAP caps are associated with restricted head growth and altered skull morphology in newborn infants
Background: Continuous positive airway pressure (CPAP) devices for preterm infants are commonly affixed using snug-fitting caps. Monitoring of head growth is standard practice in preterm infants, as stagnant head growth has been associated with impaired neurodevelopmental outcome. However, a stagnant head circumference may not mean stagnant head growth since vertical head distortion has been repeatedly observed. Previously established centiles for ear-to-ear distances and head volume indices allow the evaluation of three-dimensional head growth. We hypothesized that CPAP duration may be associated with restricted head circumference gain, altered skull morphology, and possibly neurodevelopment.Patients and methods: All 4590 infants treated with CPAP in the neonatal wards of Leipzig University Medical Center between 2009 and 2020 were included in our study. Body weight, body length, occipitofrontal head circumference (OFC), and transvertical (vEED) and transfontanellar ear-to-ear (fEED) distances were measured repeatedly. Head eccentricity (ECC) (a measure of disproportional head growth) and head volume indices (HVI) were calculated. Anthropometric data were z-transformed. A total of 367 infants were followed up for assessment of neurodevelopmental outcomes using the Bayley Scales of Infant and Toddler Development (third edition). Associations between cumulative cap time and anthropometric data were examined using unconditional growth models with linear mixed effects. Associations between head growth development and neurodevelopmental outcome were examined by correlating individual regression slopes of anthropometric data with Bayley scores.Results: Cumulative cap time was negatively associated with z-scores of OFC (, ), vEED (, ], fEED (, ), and HVI (, ), while it was positively associated with ECC (, ). Individual OFC z-score slopes show low correlation with cognition (R = 0.07), language (R = 0.06), and motor (R = 0.01) Bayley scores. Individual vEED z-scores slopes show low correlation with cognition (R = 0.10), language (R = 0.08), and motor (R = 0.07) Bayley scores.Conclusion: CPAP caps are associated with vertical and horizontal head growth restriction and altered infant head morphology, as indicated by increasing eccentricity. The correlation of the altered growth pattern with neurodevelopmental outcome was negligible. Our findings have clinical implications for the assessment of head growth development during CPAP therapy. - Open Access
- 26 March 2025
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 110 (6) , 564-570
Effects of liberal versus restrictive transfusion strategies on intermittent hypoxaemia in extremely low birthweight infants: secondary analyses of the ETTNO randomised controlled trial
Objectives: To compare the effect of liberal versus restrictive transfusion strategies on the proportion of time (%time) spent with intermittent hypoxaemia (IH, ie, arterial haemoglobin oxygen saturation measured by pulse oximetry (SpO2) 2 recordings during postnatal days 8–49. Intervention: Randomly assigned liberal (n=268) or restrictive (n=286) transfusion strategies, defining transfusion triggers based on postnatal age and health status. Main outcome measures: %time with IH, rate and mean duration of IH episodes during postnatal days 8–49. Interaction between exposure to IH and transfusion strategies with respect to ETTNO’s composite primary outcome, death or disability at 24 months corrected age. Results: The median (quartile 1–quartile 3) %time with IH was similar between treatment groups (0.91% (0.13%–2.83%) with liberal vs 0.79% (0.16%–2.44%) with restrictive transfusions). There was no interaction between exposure to IH and transfusion strategies on outcome at 24 months. Conclusions: In infants <1000 g birth weight, a liberal transfusion strategy did not reduce IH. Blood transfusions should not be administered ‘liberally’ to reduce IH or to improve neurocognitive outcome in infants with above-average exposure to IH. Trial registration number: NCT01393496.
- 26 March 2025
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 110 (6) , 564-570
Open AccessEffects of liberal versus restrictive transfusion strategies on intermittent hypoxaemia in extremely low birthweight infants: secondary analyses of the ETTNO randomised controlled trial
Objectives: To compare the effect of liberal versus restrictive transfusion strategies on the proportion of time (%time) spent with intermittent hypoxaemia (IH, ie, arterial haemoglobin oxygen saturation measured by pulse oximetry (SpO2) 2 recordings during postnatal days 8–49. Intervention: Randomly assigned liberal (n=268) or restrictive (n=286) transfusion strategies, defining transfusion triggers based on postnatal age and health status. Main outcome measures: %time with IH, rate and mean duration of IH episodes during postnatal days 8–49. Interaction between exposure to IH and transfusion strategies with respect to ETTNO’s composite primary outcome, death or disability at 24 months corrected age. Results: The median (quartile 1–quartile 3) %time with IH was similar between treatment groups (0.91% (0.13%–2.83%) with liberal vs 0.79% (0.16%–2.44%) with restrictive transfusions). There was no interaction between exposure to IH and transfusion strategies on outcome at 24 months. Conclusions: In infants <1000 g birth weight, a liberal transfusion strategy did not reduce IH. Blood transfusions should not be administered ‘liberally’ to reduce IH or to improve neurocognitive outcome in infants with above-average exposure to IH. Trial registration number: NCT01393496.
- 1 January 2025
- Published by Georg Thieme Verlag KG
Erkrankungen der Atemwege und Beatmung
- Open Access
Inhibition of epithelial Na + transport: novel mechanism of Ureaplasma -driven lung disease
Background: Respiratory tract colonisation with Ureaplasma species has been associated with the development of acute and long-term pulmonary morbidity in preterm infants. Apart from inflammation, the underlying mechanisms of Ureaplasma -driven lung disease are mainly unknown. The present investigation is the first to examine the influence of acute Ureaplasma infection on critical mechanisms of alveolar fluid clearance in the immature lung. Methods: Primary rat fetal distal lung epithelial (FDLE) cells were incubated with viable Ureaplasma in the absence or presence of the urease inhibitor flurofamide. Na + transport and activity of the epithelial Na + channel (ENaC) and the Na,K-ATPase were determined in Ussing chambers. Barrier integrity, metabolic activity, gene expression, and kinase signalling were also assessed. Results: We found a 30-90% decrease of epithelial Na + transport upon 24 hours of Ureaplasma infection resulting from significant inhibition of ENaC and Na,K-ATPase activities. Notably, Ureaplasma induced phosphorylation of Erk1/2 – a well-known inhibitor of ENaC activity. Moreover, Ureaplasma- driven NH 3 production - and not the accompanying pH shift - inhibited the epithelial Na + transport. Co-incubation with flurofamide entirely restored Na + transport in Ureaplasma -infected FDLE cells. Conclusion: Our data demonstrate that Ureaplasma infection significantly impairs epithelial Na + transport and subsequent fluid clearance in fetal alveolar cells – most likely by Erk1/2 phosphorylation. We identified NH 3 as the mediating virulence factor and were able to restore Na + transport by inhibiting the Ureaplasma -specific urease. This is the first study to show a functional impairment of pulmonary epithelial cells upon Ureaplasma infection, revealing a potential mechanism of Ureaplasma -driven preterm lung disease. Take Home: We report Ureaplasma -induced inhibition of epithelial Na + transport as a potential mechanism of Ureaplasma -driven preterm lung disease. NH 3 is identified as a virulence factor offering a potential therapeutic role for urease inhibitors in colonised infants.
Open AccessInhibition of epithelial Na + transport: novel mechanism of Ureaplasma -driven lung disease
Background: Respiratory tract colonisation with Ureaplasma species has been associated with the development of acute and long-term pulmonary morbidity in preterm infants. Apart from inflammation, the underlying mechanisms of Ureaplasma -driven lung disease are mainly unknown. The present investigation is the first to examine the influence of acute Ureaplasma infection on critical mechanisms of alveolar fluid clearance in the immature lung. Methods: Primary rat fetal distal lung epithelial (FDLE) cells were incubated with viable Ureaplasma in the absence or presence of the urease inhibitor flurofamide. Na + transport and activity of the epithelial Na + channel (ENaC) and the Na,K-ATPase were determined in Ussing chambers. Barrier integrity, metabolic activity, gene expression, and kinase signalling were also assessed. Results: We found a 30-90% decrease of epithelial Na + transport upon 24 hours of Ureaplasma infection resulting from significant inhibition of ENaC and Na,K-ATPase activities. Notably, Ureaplasma induced phosphorylation of Erk1/2 – a well-known inhibitor of ENaC activity. Moreover, Ureaplasma- driven NH 3 production - and not the accompanying pH shift - inhibited the epithelial Na + transport. Co-incubation with flurofamide entirely restored Na + transport in Ureaplasma -infected FDLE cells. Conclusion: Our data demonstrate that Ureaplasma infection significantly impairs epithelial Na + transport and subsequent fluid clearance in fetal alveolar cells – most likely by Erk1/2 phosphorylation. We identified NH 3 as the mediating virulence factor and were able to restore Na + transport by inhibiting the Ureaplasma -specific urease. This is the first study to show a functional impairment of pulmonary epithelial cells upon Ureaplasma infection, revealing a potential mechanism of Ureaplasma -driven preterm lung disease. Take Home: We report Ureaplasma -induced inhibition of epithelial Na + transport as a potential mechanism of Ureaplasma -driven preterm lung disease. NH 3 is identified as a virulence factor offering a potential therapeutic role for urease inhibitors in colonised infants.
- Open Access
- 24 October 2023
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 11, 1235877
Similar adverse outcome rates with high or low oxygen saturation targets in an area with low background mortality
Background: Randomized controlled trials have indicated reduced mortality rates in very preterm infants assigned to high compared to low oxygen saturation (SpO2) target levels, accompanied by higher rates of retinopathy of prematurity and bronchopulmonary dysplasia. However, the benefit-to-harm ratio may depend on the local background mortality risk. We therefore aimed to quantify the risk–benefit ratios of different SpO2 target ranges in 10 tertiary newborn intensive care units (NICUs) in East Germany.Methods: In a retrospective multicenter study, 1,399 infants born between 2008 and 2012 at a gestational age between 24 0/7 and 27 6/7 weeks and with a birthweight below 1,250 g were grouped according to the hospital's target SpO2 range [high oxygen saturation group (HOSG) above 90%], low oxygen saturation group (LOSG) below 90%] and the compliance of units with their target SpO2 range. The association between neonatal morbidities, neurodevelopmental outcomes, selected treatment strategies, and target SpO2 ranges was calculated using chi-squared and Mann Whitney U tests.Results: Nine of the ten participating NICUs met their SpO2 target ranges. Five units were considered as HOSG, and five units were considered as LOSG. Necrotizing enterocolitis and intraventricular hemorrhage grade ≥ 2 occurred significantly more frequently in the HOSG than in the LOSG (8.4% vs. 5.1%, p = 0.02; and 26.6% vs. 17.7%, p < 0.001). No significant differences in the mortality rate and the rate of retinopathy of prematurity were found.Conclusion: In our patient population, a lower SpO2 target range was not associated with increased safety risks in extremely preterm infants. We cannot be sure that our outcome differences are associated with differences in oxygen saturations due to the retrospective study design and the differences in site practices.
- 24 October 2023
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 11, 1235877
Open AccessSimilar adverse outcome rates with high or low oxygen saturation targets in an area with low background mortality
Background: Randomized controlled trials have indicated reduced mortality rates in very preterm infants assigned to high compared to low oxygen saturation (SpO2) target levels, accompanied by higher rates of retinopathy of prematurity and bronchopulmonary dysplasia. However, the benefit-to-harm ratio may depend on the local background mortality risk. We therefore aimed to quantify the risk–benefit ratios of different SpO2 target ranges in 10 tertiary newborn intensive care units (NICUs) in East Germany.Methods: In a retrospective multicenter study, 1,399 infants born between 2008 and 2012 at a gestational age between 24 0/7 and 27 6/7 weeks and with a birthweight below 1,250 g were grouped according to the hospital's target SpO2 range [high oxygen saturation group (HOSG) above 90%], low oxygen saturation group (LOSG) below 90%] and the compliance of units with their target SpO2 range. The association between neonatal morbidities, neurodevelopmental outcomes, selected treatment strategies, and target SpO2 ranges was calculated using chi-squared and Mann Whitney U tests.Results: Nine of the ten participating NICUs met their SpO2 target ranges. Five units were considered as HOSG, and five units were considered as LOSG. Necrotizing enterocolitis and intraventricular hemorrhage grade ≥ 2 occurred significantly more frequently in the HOSG than in the LOSG (8.4% vs. 5.1%, p = 0.02; and 26.6% vs. 17.7%, p < 0.001). No significant differences in the mortality rate and the rate of retinopathy of prematurity were found.Conclusion: In our patient population, a lower SpO2 target range was not associated with increased safety risks in extremely preterm infants. We cannot be sure that our outcome differences are associated with differences in oxygen saturations due to the retrospective study design and the differences in site practices.
- Open Access
- 3 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4919
Imbalanced Inflammatory Responses in Preterm and Term Cord Blood Monocytes and Expansion of the CD14+CD16+ Subset upon Toll-like Receptor Stimulation
Developmentally regulated features of innate immunity are thought to place preterm and term infants at risk of infection and inflammation-related morbidity. Underlying mechanisms are incompletely understood. Differences in monocyte function including toll-like receptor (TLR) expression and signaling have been discussed. Some studies point to generally impaired TLR signaling, others to differences in individual pathways. In the present study, we assessed mRNA and protein expression of pro- and anti-inflammatory cytokines in preterm and term cord blood (CB) monocytes compared with adult controls stimulated ex vivo with Pam3CSK4, zymosan, polyinosinic:polycytidylic acid, lipopolysaccharide, flagellin, and CpG oligonucleotide, which activate the TLR1/2, TLR2/6, TLR3, TLR4, TLR5, and TLR9 pathways, respectively. In parallel, frequencies of monocyte subsets, stimulus-driven TLR expression, and phosphorylation of TLR-associated signaling molecules were analyzed. Independent of stimulus, pro-inflammatory responses of term CB monocytes equaled adult controls. The same held true for preterm CB monocytes—except for lower IL-1β levels. In contrast, CB monocytes released lower amounts of anti-inflammatory IL-10 and IL-1ra, resulting in higher ratios of pro-inflammatory to anti-inflammatory cytokines. Phosphorylation of p65, p38, and ERK1/2 correlated with adult controls. However, stimulated CB samples stood out with higher frequencies of intermediate monocytes (CD14+CD16+). Both pro-inflammatory net effect and expansion of the intermediate subset were most pronounced upon stimulation with Pam3CSK4 (TLR1/2), zymosan (TR2/6), and lipopolysaccharide (TLR4). Our data demonstrate robust pro-inflammatory and yet attenuated anti-inflammatory responses in preterm and term CB monocytes, along with imbalanced cytokine ratios. Intermediate monocytes, a subset ascribed pro-inflammatory features, might participate in this inflammatory state.
- 3 March 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (5) , 4919
Open AccessImbalanced Inflammatory Responses in Preterm and Term Cord Blood Monocytes and Expansion of the CD14+CD16+ Subset upon Toll-like Receptor Stimulation
Developmentally regulated features of innate immunity are thought to place preterm and term infants at risk of infection and inflammation-related morbidity. Underlying mechanisms are incompletely understood. Differences in monocyte function including toll-like receptor (TLR) expression and signaling have been discussed. Some studies point to generally impaired TLR signaling, others to differences in individual pathways. In the present study, we assessed mRNA and protein expression of pro- and anti-inflammatory cytokines in preterm and term cord blood (CB) monocytes compared with adult controls stimulated ex vivo with Pam3CSK4, zymosan, polyinosinic:polycytidylic acid, lipopolysaccharide, flagellin, and CpG oligonucleotide, which activate the TLR1/2, TLR2/6, TLR3, TLR4, TLR5, and TLR9 pathways, respectively. In parallel, frequencies of monocyte subsets, stimulus-driven TLR expression, and phosphorylation of TLR-associated signaling molecules were analyzed. Independent of stimulus, pro-inflammatory responses of term CB monocytes equaled adult controls. The same held true for preterm CB monocytes—except for lower IL-1β levels. In contrast, CB monocytes released lower amounts of anti-inflammatory IL-10 and IL-1ra, resulting in higher ratios of pro-inflammatory to anti-inflammatory cytokines. Phosphorylation of p65, p38, and ERK1/2 correlated with adult controls. However, stimulated CB samples stood out with higher frequencies of intermediate monocytes (CD14+CD16+). Both pro-inflammatory net effect and expansion of the intermediate subset were most pronounced upon stimulation with Pam3CSK4 (TLR1/2), zymosan (TR2/6), and lipopolysaccharide (TLR4). Our data demonstrate robust pro-inflammatory and yet attenuated anti-inflammatory responses in preterm and term CB monocytes, along with imbalanced cytokine ratios. Intermediate monocytes, a subset ascribed pro-inflammatory features, might participate in this inflammatory state.